Works matching DE "BLOOD coagulation factor VII"
Results: 24
The Danger of Using a Sledgehammer to Crack a Nut: ROTEM-Guided Administration of Recombinant Activated Factor VII in a Patient With Refractory Bleeding Post-Ventricular Assist Device Implantation.
- Published in:
- Artificial Organs, 2015, v. 39, n. 3, p. 248, doi. 10.1111/aor.12355
- By:
- Publication type:
- Article
The first reported case of acquired haemophilia A in which bleeding episodes were successfully treated via administration of a single‐dose mixture of activated factor VIIa/X.
- Published in:
- Haemophilia, 2019, v. 25, n. 5, p. e350, doi. 10.1111/hae.13843
- By:
- Publication type:
- Article
Kinetic analysis and binding studies of a new recombinant human factor VIIa for treatment of haemophilia.
- Published in:
- Haemophilia, 2017, v. 23, n. 2, p. 300, doi. 10.1111/hae.13110
- By:
- Publication type:
- Article
Inhibitor development after liver transplantation in congenital factor VII deficiency.
- Published in:
- Haemophilia, 2016, v. 22, n. 5, p. e417, doi. 10.1111/hae.13047
- By:
- Publication type:
- Article
The molecular basis of low activity levels of coagulation factor VII: a Brazilian cohort.
- Published in:
- Haemophilia, 2015, v. 21, n. 5, p. 670, doi. 10.1111/hae.12645
- By:
- Publication type:
- Article
Changes in von Willebrand factor level and von Willebrand activity with age in type 1 von Willebrand disease.
- Published in:
- Haemophilia, 2015, v. 21, n. 5, p. 636, doi. 10.1111/hae.12664
- By:
- Publication type:
- Article
Switching to low dose of plasma-derived factor VIII/ vWF concentrates with Confact<sup>®</sup>-F as salvage immune tolerance induction in haemophilia A patients with inhibitors: five case reports from Japan.
- Published in:
- Haemophilia, 2015, v. 21, n. 5, p. e425, doi. 10.1111/hae.12728
- By:
- Publication type:
- Article
Successful use of recombinant factor VIIa in a patient with acquired Glanzmann thrombasthenia.
- Published in:
- Haemophilia, 2015, v. 21, n. 1, p. e116, doi. 10.1111/hae.12589
- By:
- Publication type:
- Article
Inhibitors to factor VII in congenital factor VII deficiency.
- Published in:
- Haemophilia, 2014, v. 20, n. 2, p. e188, doi. 10.1111/hae.12376
- By:
- Publication type:
- Article
On-demand treatment of bleeds in haemophilia patients with inhibitors: strategies for securing and maintaining predictable efficacy with recombinant activated factor VII.
- Published in:
- Haemophilia, 2012, v. 18, n. 2, p. 255, doi. 10.1111/j.1365-2516.2011.02612.x
- By:
- Publication type:
- Article
Tissue Factor--Factor VII Complex As a Key Regulator of Ovarian Cancer Phenotypes.
- Published in:
- Biomarkers in Cancer, 2015, n. 7, p. 1, doi. 10.4137/BIC.s29318
- By:
- Publication type:
- Article
P341Activation of beta1-integrins and caveolin-1 by TF/FVIIa promotes cell survival.
- Published in:
- 2018
- By:
- Publication type:
- Abstract
Comparison of Fresh-Frozen Plasma, Four-Factor Prothrombin Complex Concentrates, and Recombinant Factor VIIa to Facilitate Procedures in Critically Ill Patients with Coagulopathy from Liver Disease: A Retrospective Cohort Study.
- Published in:
- Pharmacotherapy, 2016, v. 36, n. 10, p. 1047, doi. 10.1002/phar.1827
- By:
- Publication type:
- Article
Recombinant activated factor VII in patients with acute liver failure with UNOS Status 1 A: a single tertiary academic centre experience.
- Published in:
- Vox Sanguinis, 2014, v. 106, n. 1, p. 75, doi. 10.1111/vox.12067
- By:
- Publication type:
- Article
Alternatives to allogeneic platelet transfusion.
- Published in:
- British Journal of Haematology, 2016, v. 175, n. 3, p. 381, doi. 10.1111/bjh.14338
- By:
- Publication type:
- Article
Dabigatran and its reversal with recombinant factor VIIa and prothrombin complex concentrate: A Sonoclot in vitro study.
- Published in:
- Scandinavian Journal of Clinical & Laboratory Investigation, 2014, v. 74, n. 7, p. 591, doi. 10.3109/00365513.2014.921930
- By:
- Publication type:
- Article
Use of Activated Factor VII in Patients with Diffuse Alveolar Hemorrhage: A 10 Years Institutional Experience.
- Published in:
- Lung, 2015, v. 193, n. 3, p. 375, doi. 10.1007/s00408-015-9720-z
- By:
- Publication type:
- Article
Recombinant factor VIIa as a rescue therapy in severe haemoptysis in a patient with a Fontan circulation.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Strategies for inhibitor treatment and costs in the short and long term: a critical evaluation of recent clinical studies.
- Published in:
- European Journal of Haematology, 2015, v. 94, p. 30, doi. 10.1111/ejh.12499
- By:
- Publication type:
- Article
Successful Control of Massive Bleeding in a Child with Burkitt’s Lymphoma via a Biosimilar Recombinant Activated Factor VII (AryoSeven™).
- Published in:
- 2016
- By:
- Publication type:
- Case Study
Successful treatment of intracranial hemorrhage with recombinant activated factor VII in a patient with newly diagnosed acute myeloid leukemia: a case report and review of the literature.
- Published in:
- 2015
- By:
- Publication type:
- Case Study
Mechanisms of coexistence of factor VII hyperactivity with dyslipidaemia, diabetes mellitus, obesity and its role in the development of myocardial infarction: A review.
- Published in:
- African Journal for Physical, Health Education, Recreation & Dance, 2015, v. 21, n. 2:2, p. 519
- By:
- Publication type:
- Article
Association of elevated Factor VII activity with hyperglycaemia, dyslipidaemia and obesity in a rural black community in Limpopo Province, South Africa.
- Published in:
- African Journal for Physical, Health Education, Recreation & Dance, 2013, v. 19, n. 3, p. 555
- By:
- Publication type:
- Article
Cost-effectiveness of using recombinant activated factor VII as an off-label rescue treatment for critical bleeding requiring massive transfusion.
- Published in:
- Transfusion, 2012, v. 52, n. 8, p. 1696, doi. 10.1111/j.1537-2995.2011.03505.x
- By:
- Publication type:
- Article